| Patents > Guidance, Tools, and Manuals > Classification > Class Schedule |
|
|
|
| Class Numbers & Titles | Class Numbers Only | USPC Index | International | HELP |
|
| You are viewing a USPC Schedule. |
|
| Class 435 | CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY |
| Click here for a printable version of this file | |
![[List of Pre Grant Publications for class 435 subclass 1.1]](../as.gif) | ![[List of Patents for class 435 subclass 1.1]](../ps.gif) | 1.1 | DIFFERENTIATED TISSUE OR ORGAN OTHER THAN BLOOD, PER SE, OR DIFFERENTIATED TISSUE OR ORGAN MAINTAINING; COMPOSITION THEREFOR |
| | 2 | MAINTAINING BLOOD OR SPERM IN A PHYSIOLOGICALLY ACTIVE STATE OR COMPOSITIONS THEREOF OR THEREFOR OR METHODS OF IN VITRO BLOOD CELL SEPARATION OR TREATMENT |
| | 3 | CONDITION RESPONSIVE CONTROL PROCESS |
| | 4 | MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP |
| | 5 |  Involving virus or bacteriophage |
| | 6.1 | Involving nucleic acid |
| | 6.12 |  With significant amplification step (e.g., polymerase chain reaction (PCR), etc.) |
| | 6.13 | Drug or compound screening involving gene expression |
| | 6.14 | Detecting cancer |
| | 6.15 | Involving bacterium, fungus, parasite or protozoan (e.g., detecting pathogen virulence factors, adhesions, toxins, etc.) |
| | 6.16 | Involving a nucleic acid encoding a protein related to the nervous system, (e.g., nerve related factors, brain-derived cytokines, nerve cell biomarker, etc.) |
| | 6.17 | Involving a nucleic acid encoding a receptor, cytokine, hormone, growth factor, ion channel protein, or membrane transporter protein |
| | 6.18 | Involving a nucleic acid encoding an enzyme |
| | 6.19 | Detecting nucleic acid by specific antibody, protein or ligand-receptor binding assay |
| | 7.1 | Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay |
| | 7.2 | Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate |
| | 7.21 |  Animal cell |
| | 7.22 |  Parasite or protozoa |
| | 7.23 | Tumor cell or cancer cell |
| | 7.24 | Leukocyte (e.g., lymphocyte, granulocyte, monocyte, etc.) |
| | 7.25 | Erythrocyte |
| | 7.3 | Flagellar-antigen or pili-antigen |
| | 7.31 | Fungi (e.g., yeast, mold, etc.) |
| | 7.32 | Bacteria or actinomycetales |
| | 7.4 | To identify an enzyme or isoenzyme |
| | 7.5 | Involving avidin-biotin binding |
| | 7.6 | Involving a modified enzyme (e.g., abzyme, recombinant, chemically altered, etc.) |
| | 7.7 | Assay in which a label present is an apoenzyme, prosthetic group, or enzyme cofactor |
| | 7.71 | Assay in which a label present is an enzyme inhibitor or functions to alter enzyme activity |
| | 7.72 | Assay in which a label present is an enzyme substrate or substrate analogue |
| | 7.8 | Involving nonmembrane bound receptor binding or protein binding other than antigen-antibody binding |
| | 7.9 | Assay in which an enzyme present is a label |
| | 8 | Involving luciferase |
| | 9 | Geomicrobiological testing (e.g., for petroleum, etc.) |
| | 10 | Involving uric acid |
| | 11 | Involving cholesterol |
| | 12 | Involving urea or urease |
| | 13 | Involving blood clotting factor (e.g., involving thrombin, thromboplastin, fibrinogen, etc.) |
| | 14 | Involving glucose or galactose |
| | 15 | Involving transferase |
| | 18 | Involving hydrolase |
| | 25 | Involving oxidoreductase |
| | 29 | Involving viable micro-organism |
| | 30 | Methods of sampling or inoculating or spreading a sample; methods of physically isolating an intact micro-organism |
| | 31 | Testing for sterility condition |
| | 32 | Testing for antimicrobial activity of a material |
| | 34 | Determining presence or kind of micro-organism; use of selective media |
| | 40.5 | Involving fixed or stabilized, nonliving microorganism, cell, or tissue (e.g., processes of staining, stabilizing, dehydrating, etc.; compositions used therefore, etc.) |
| | 41 | MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION |
| | 42 | Process involving micro-organisms of different genera in the same process, simultaneously |
| | 43 | Preparing compound having a 1-thia-4-aza-bicyclo (3.2.0) heptane ring system (e.g., penicillin, etc.) |
| | 44 | By desacylation of the substituent in 6-position |
| | 45 | By acylation of the substituent in 6-position |
| | 46 | In presence of phenyl acetic acid or phenyl acetamide or their derivatives |
| | 47 | Preparing compound having a 1-thia-5-aza-bicyclo (4.2.0) octane ring system (e.g., cephalosporin, etc.) |
| | 48 | Di-substituted in 7-position |
| | 49 | Cephalosporin C |
| | 50 | By acylation of the substituent in the 7-position |
| | 51 | By desacylation of the substituent in the 7-position |
| | 52 | Preparing compound containing a cyclopentanohydrophenanthrene nucleus; nor-, homo-, or D-ring lactone derivatives thereof |
| | 53 | Containing heterocyclic ring |
| | 54 | Acting on D-ring |
| | 58 | Hydroxylating |
| | 61 | Dehydrogenating; dehydroxylating |
| | 63 | Preparing compound containing a prostaglandin nucleus |
| | 64 | Preparing compound other than saccharide containing a tetracycline nucleus (e.g., naphacene, etc.) |
| | 65 | Preparing compound other than saccharide containing a gibberellin nucleus (i.e., gibbane) |
| | 66 | Preparing compound other than saccharide containing alloxazine or isoalloxazine nucleus |
| | 67 | Preparing compound containing a carotene nucleus (i.e., carotene) |
| | 68.1 | Enzymatic production of a protein or polypeptide (e.g., enzymatic hydrolysis, etc.) |
| | 69.1 | Recombinant DNA technique included in method of making a protein or polypeptide |
| | 69.2 | Enzyme inhibitors or activators |
| | 69.3 | Antigens |
| | 69.4 | Hormones and fragments thereof |
| | 69.5 | Lymphokines or monokines |
| | 69.6 | Blood proteins |
| | 69.7 | Fusion proteins or polypeptides |
| | 69.8 | Signal sequence (e.g., beta-galactosidase, etc.) |
| | 70.1 | Using tissue cell culture to make a protein or polypeptide |
| | 71.1 | Using a micro-organism to make a protein or polypeptide |
| | 72 | Preparing compound containing saccharide radical |
| | 73 | Preparing S-glycoside (e.g., lincomycin, etc.) |
| | 74 | Preparing O-glycoside (e.g., glucosides, etc.) |
| | 76 | The hetero ring has eight or more ring members and only oxygen as ring hetero atoms (e.g., erythromycin, spiramycin, nystatin, etc.) |
| | 77 | Oxygen atom of the saccharide radical is directly linked through only acyclic carbon atoms to a nonsaccharide heterocyclic ring (e.g., bleomycin, phleomycin, etc.) |
| | 78 | Oxygen atom of the saccharide radical is directly bonded to a condensed ring system having three or more carboxyclic rings (e.g., dauomycin, adriamycin, etc.) |
| | 79 | Oxygen atom of the saccharide radical is bonded to a cyclohexyl radical (e.g., kasugamycin, etc.) |
| | 80 | Cyclohexyl radical is substituted by two or more nitrogen atoms (e.g., destomycin, neamin, etc.) |
| | 84 | Preparing nitrogen-containing saccharide |
| | 85 | N-glycoside |
| | 86 | Cobalamin (i.e., vitamin B12, LLD factor) |
| | 87 | Nucleoside |
| | 88 |  Having a fused ring containing a six-membered ring having two N-atoms in the same ring (e.g., purine nucleosides, etc.) |
| | 89 | Nucleotide |
| | 90 | Dinucleotide (e.g., NAD, etc.) |
| | 91.1 | Polynucleotide (e.g., nucleic acid, oligonucleotide, etc.) |
| | 91.2 |  Acellular exponential or geometric amplification (e.g., PCR, etc.) |
| | 91.3 | Polynucleotide contains only ribonucleotide monomers |
| | 91.4 | Modification or preparation of a recombinant DNA vector |
| | 91.41 |  By insertion or addition of one or more nucleotides |
| | 91.42 | Involving deletion of a nucleotide or nucleotides from a vector |
| | 91.5 | Acellular preparation of polynucleotide |
| | 92 | Having a fused ring containing a six-membered ring having two N-atoms in the same ring (e.g., purine based mononucleotides, etc.) |
| | 93 | Mashing or wort making |
| | 94 | Produced by the action of an isomerase (e.g., fructose by the action of xylose isomerase on glucose, etc.) |
| | 95 | Produced by the action of a beta-amylase (e.g., maltose by the action of beta-amylase on amylose, etc.) |
| | 96 | Produced by the action of an exo-1.4 alpha glucosidase (e.g., dextrose by the action of glucoamylase on starch, etc.) |
| | 97 | Produced by the action of a glycosyl transferase (e.g., alpha, beta, gamma-cyclodextrins by the action of glycosyl transferase on starch, etc.) |
| | 98 | Produced by the action of an alpha-1, 6-glucosidase (e.g., amylose debranched amylopectin by the action of pullulanase, etc.) |
| | 99 | Produced by the action of a carbohydrase (e.g., maltose by the action of alpha amylase on starch, etc.) |
| | 100 | Disaccharide |
| | 101 | Polysaccharide of more than five saccharide radicals attached to each other by glycosidic bonds |
| | 105 | Monosaccharide |
| | 106 | Preparing alpha or beta amino acid or substituted amino acid or salts thereof |
| | 107 | Proline; hydroxyproline; histidine |
| | 108 | Tryptophan; tyrosine; phenylalanine; 3,4 dihydroxyphenylalanine |
| | 109 | Aspartic acid (asparaginic acid); asparagine |
| | 110 | Glutamic acid; glutamine |
| | 111 | Utilizing biotin or its derivatives |
| | 112 | Utilizing surfactant fatty acids or fatty acid esters (i.e., having seven or more atoms) |
| | 113 | Methionine; cysteine; cystine |
| | 114 | Citrulline; arginine; ornithine |
| | 115 | Lysine; diaminopimelic acid; threonine; valine |
| | 116 | Alanine; leucine; isoleucine; serine; homoserine |
| | 117 | Preparing heterocyclic carbon compound having only O, N, S, Se, or Te as ring hetero atoms |
| | 118 | Containing two or more hetero rings |
| | 119 | Containing at least two hetero rings bridged or fused among themselves or bridged or fused with a common carbocyclic ring system, (e.g., rifamycin, etc.) |
| | 120 | Nitrogen or oxygen hetero atom and at least one other diverse hetero ring atom in the same ring |
| | 121 | Nitrogen as only ring hetero atom |
| | 123 | Oxygen as only ring hetero atom |
| | 127 | Preparing compound containing at least three carbocyclic rings |
| | 128 | Preparing nitrogen-containing organic compound |
| | 130 | Preparing sulfur-containing organic compound |
| | 131 | Preparing organic compound containing a metal or atom other than H, N, C, O, or halogen |
| | 132 | Preparing oxygen-containing organic compound |
| | 133 | Containing quinone nucleus (i.e., quinoid structure) |
| | 134 | Fat; fatty oil; ester-type wax; higher fatty acid (i.e., having at least seven carbon atoms in an unbroken chain bound to a carboxyl group); oxidized oil or fat |
| | 135 | Carboxylic acid ester |
| | 136 | Containing a carboxyl group |
| | 137 | Sugar acid having five or more carbon atoms (i.e., aldonic, keto-aldonic, or saccharic acid) |
| | 139 | Lactic acid |
| | 140 | Acetic acid |
| | 141 | Propionic or butyric acid |
| | 142 | Polycarboxylic acid |
| | 143 | Having keto group (e.g., alpha-ketoglutaric acid, etc.) |
| | 144 | Tricarboxylic acid (e.g., citric acid, etc.) |
| | 145 | Dicarboxylic acid having four or less carbon atoms (e.g., fumaric, maleic, etc.) |
| | 146 | Hydroxy carboxylic acid |
| | 147 | Containing carbonyl group |
| | 155 | Containing hydroxy group |
| | 166 | Preparing hydrocarbon |
| | 168 | Preparing element or inorganic compound except carbon dioxide |
| | 169 | Using actinomycetales |
| | 170 | Using bacteria |
| | 171 | Using fungi |
| | 440 | PROCESS OF MUTATION, CELL FUSION, OR GENETIC MODIFICATION |
| | 441 | Mutation employing a chemical mutagenic agent |
| | 442 | By replacement of standard nucleic acid base with base analog (e.g., 5-bromouracil, etc.) |
| | 443 | By use of intercalating agent (e.g., acridine orange, etc.) |
| | 444 | By use of alkylating agent (e.g., nitrosoguanidine, etc.) |
| | 445 | By use of oxidative deamination agent (e.g., nitrous acid, etc.) |
| | 446 | Mutation employing radiation or electricity |
| | 449 | Fusion of cells |
| | 450 | Employing electric current |
| | 451 | One of the fusing cells is a human antibody-producing cell |
| | 452 | One of the fusing cells is a mouse antibody-producing cell |
| | 453 | One of the fusing cells is a plant cell |
| | 454 | One of the fusing cells is a microorganism (e.g., prokaryote, fungus, etc.) |
| | 455 | Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within an animal cell |
| | 456 | The polynucleotide is encapsidated within a virus or viral coat |
| | 458 | The polynucleotide is coated with or encapsulated within a lipid containing material (e.g., liposome, etc.) |
| | 459 | Involving particle-mediated transfection (i.e., biolistic transfection) |
| | 460 | Involving laser treatment of the cell before or during transfection |
| | 461 | Involving electroporation |
| | 462 | Involving site-specific recombination (e.g., Cre-lox, etc.) |
| | 463 | Involving general or homologous recombination (e.g., gene targeting, etc.) |
| | 464 | Involving gene duplication within the cell (e.g., amplification, co-amplification, etc.) |
| | 465 | Involving co-transfection |
| | 466 | The polynucleotide is a shuttle vector or a transiently replicating hybrid vector |
| | 467 | Introducing an oncogene to establish a cell line |
| | 468 | Introduction of a polynucleotide molecule into or rearrangement of a nucleic acid within a plant cell |
| | 469 | Introduction via Agrobacterium |
| | 470 | Introduction via electroporation, particle, fiber or microprojectile mediated insertion, or injection |
| | 471 | Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within a microorganism (e.g., bacteria, protozoa, bacteriophage, etc.) |
| | 472 | The polynucleotide is encapsidated within a bacteriophage, bacteriophage coat, or transducing particle |
| | 473 | The polynucleotide contains a transposon |
| | 474 | The polynucleotide is a cosmid |
| | 475 | The polynucleotide is unencapsidated bacteriophage or viral nucleic acid |
| | 476 | The polynucleotide is a plasmid or episome |
| | 477 | Plasmid or episome contains DNA targeting homologous recombination to bacteriophage, viral, or chromosomal DNA within a microorganism |
| | 478 | Plasmid or episome contains at least part of a gene encoding a restriction endonuclease or modification enzyme |
| | 479 | Plasmid or episome confers the ability to utilize directly a compound which a wild type microorganism is unable to utilize |
| | 480 | Plasmid or episome contains at least part of a gene encoding a toxin or encoding for virulence or pathogenicity |
| | 481 | Plasmid or episome contains a gene which complements a nutritional deficiency mutation |
| | 482 | Plasmid or episome contains a gene which confers resistance to metal, silicon, selenium, or tellurium toxicity |
| | 483 | Yeast is a host for the plasmid or episome |
| | 484 | Mycelial fungus is a host for the plasmid or episome |
| | 485 | Microorganism of the genus Bacillus is a host for the plasmid or episome |
| | 486 | Microorganism of the genus Streptomyces is a host for the plasmid or episome |
| | 487 | Microorganism of the genus Brevibacterium or the genus Corynebacterium is a host for the plasmid or episome |
| | 488 | Microorganism of the genus Escherichia is a host for the plasmid or episome |
| | 489 | Plural nonidentical plasmids are introduced into a host microorganism or culture thereof (e.g., plasmid is part of a library, etc.) |
| | 490 | The polynucleotide is an unbranched linear fragment |
| | 173.1 | TREATMENT OF MICRO-ORGANISMS OR ENZYMES WITH ELECTRICAL OR WAVE ENERGY (E.G., MAGNETISM, SONIC WAVES, ETC.) |
| | 173.2 | Enzyme treated |
| | 173.3 | Modification of viruses (e.g., attenuation, etc.) |
| | 173.4 | Cell membrane or cell surface is target |
| | 173.5 | Membrane permeability increased |
| | 173.7 | Lytic effect produced (e.g., disruption of cell membrane for release of subcellular parts; e.g., nucleic acids, etc.) |
| | 173.8 | Metabolism of micro-organism enhanced (e.g., growth enhancement or increased production of microbial product) |
| | 173.9 | Concentration, separation, or purification of micro-organisms |
| | 174 | CARRIER-BOUND OR IMMOBILIZED ENZYME OR MICROBIAL CELL; CARRIER-BOUND OR IMMOBILIZED CELL; PREPARATION THEREOF |
| | 175 | Multi-enzyme system |
| | 176 | Enzyme or microbial cell is immobilized on or in an inorganic carrier |
| | 177 | Enzyme or microbial cell is immobilized on or in an organic carrier |
| | 183 | ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES |
| | 184 | Enzyme inactivation by chemical treatment |
| | 185 | Malt |
| | 186 | Pancreatin |
| | 187 | Preparing granular- or free-flowing enzyme composition |
| | 188 | Stablizing an enzyme by forming a mixture, an adduct or a composition, or formation of an adduct or enzyme conjugate |
| | 188.5 | Catalytic antibody |
| | 189 | Oxidoreductase (1. ) (e.g., luciferase) |
| | 190 | Acting on CHOH group as donor (e.g., glucose oxidase, lactate dehydrogenase (1.1)) |
| | 191 | Acting on nitrogen-containing compound as donor (1.2, 1.5, 1.7) |
| | 192 | Acting on hydrogen peroxide as acceptor (1.11) |
| | 193 | Transferase other than ribonuclease (2.) |
| | 195 | Hydrolase (3. ) |
| | 196 | Acting on ester bond (3.1) |
| | 200 | Acting on glycosyl compound (3.2) |
| | 201 | Acting on alpha-1, 4-glucosidic bond, (e.g., hyaluronidase, invertase, amylase, etc. (some 3.2.1)) |
| | 202 | Alpha-amylase, microbial source |
| | 204 | Alpha-amylase, plant source (3.2.1.1) |
| | 205 | Glucoamylase (3.2.1.3) |
| | 206 | Acting on beta-1, 4 link between N-acetylmuramic acid and 2-acetylamino 2 deoxy-D-glucose (e.g., lysozyme, etc.) |
| | 207 | Acting on beta-galatose-glycoside bond (e.g., beta-galactosidase, etc.) |
| | 208 | Acting on alpha-galatose-glycoside bond (e.g., alpha-galactosidase, etc.) |
| | 209 | Acting on beta-1, 4-glucosidic bond (e.g., cellulase, etc. (3.2.1.4)) |
| | 210 | Acting on alpha-1, 6-glucosidic bond (e.g., isoamylase, pullulanase, etc.) |
| | 212 | Acting on peptide bond (e.g., thromboplastin, leucine amino-peptidase, etc., (3.4)) |
| | 213 | Trypsin; chymotrypsin |
| | 214 | Thrombin |
| | 215 | Urokinase |
| | 216 | Streptokinase |
| | 217 | Plasmin (i.e., fibrinolysin) |
| | 218 | Elastase |
| | 219 | Proteinase |
| | 227 | Acting on carbon to nitrogen bond other than peptide bond (3.5) |
| | 232 | Lyase (4. ) |
| | 233 | Isomerase (5. ) |
| | 235.1 | VIRUS OR BACTERIOPHAGE, EXCEPT FOR VIRAL VECTOR OR BACTERIOPHAGE VECTOR; COMPOSITION THEREOF; PREPARATION OR PURIFICATION THEREOF; PRODUCTION OF VIRAL SUBUNITS; MEDIA FOR PROPAGATING |
| | 325 | ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE |
| | 326 | Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof |
| | 327 | Immunoglobulin or antibody is anti-idiotypic |
| | 328 | Immunoglobulin or antibody is chimeric, mutated, or a recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rFv, immunoglobuin fusion protein, etc.) |
| | 329 | Immunoglobulin or antibody binds an oligosaccharide structure other than nucleic acid |
| | 330 | Immunoglobulin or antibody binds an expression product of a cancer related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.) |
| | 331 | Immunoglobulin or antibody binds a specifically identified amino acid sequence |
| | 332 | Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.) |
| | 333 | Binds a nucleic acid or derivative or component thereof (e.g., DNA, RNA, DNA-RNA, hybrid, nucleotide, nucleoside, carcinogen-DNA adduct, etc.) |
| | 334 | Binds a receptor (e.g., transferrin receptor, Fc receptor, dihydropyridine receptor, IL-2 receptor, etc.) |
| | 337 | Binds a plasma protein, serum protein, or fibrin (e.g., clotting factor fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.) |
| | 338 | Binds an enzyme |
| | 339 | Binds a virus or component or product thereof (e.g., virus associated antigen, etc.) |
| | 340 | Binds a bacterium or similar microorganism or component or product thereof (e.g., Streptococcus, Legionella, Mycoplasma, bacterium associated antigen, exotoxin, etc.) |
| | 341 | Binds a fungus or plant cell or component or product thereof (e.g., fungus associated antigen, etc.) |
| | 342 | Binds a parasitic protozoan or metazoan cell or component or product thereof; (e.g., Dirofilaria, Eimeria, Coccidia, Trichinella, parasite cell surface antigen, etc.) |
| | 344 | Binds a cancer cell or component or product thereof (e.g., cell surface antigen, etc.) |
| | 345 | Immunoglobulin or antibody binds a drug, hapten, hapten-carrier complex, or specifically identified chemical structure (e.g., theophylline, digoxin, etc.) |
| | 346 | Fused or hybrid cell, per se |
| | 347 | Two or more cell types, per se, in co-culture |
| | 348 | Insect cell, per se |
| | 349 | Avian cell, per se |
| | 350 | Canine cell, per se |
| | 351 | Feline cell, per se |
| | 352 | Rodent cell, per se |
| | 353 | Rat (i.e., Rattus) |
| | 354 | Mouse (i.e., Mus) |
| | 355 | Blood or lymphatic origin or derivative |
| | 356 | L cell or derivative (e.g., Ltk(-), etc.) |
| | 357 | Fibroblast, fibroblast-like cell or derivative (e.g., NIH 3T3, etc.) |
| | 358 | Chinese hamster ovary (i.e., CHO) |
| | 363 | Primate cell, per se |
| | 364 | Monkey kidney |
| | 366 | Human |
| | 373 | Method of co-culturing cells |
| | 374 | Method of storing cells in a viable state |
| | 375 | Method of regulating cell metabolism or physiology |
| | 376 | Method of synchronizing cell division |
| | 377 | Method of altering the differentiation state of the cell |
| | 378 | Method of detaching cells, digesting tissue or establishing a primary culture |
| | 379 | Using mechanical means (e.g., trituration, etc.) |
| | 380 | Releasing bound or adhered cell using protease |
| | 381 | Digesting tissue with protease |
| | 382 | Method of culturing encapsulated cells |
| | 383 | Method of culturing cells in suspension |
| | 384 | Culture medium contains a growth factor or growth regulator |
| | 385 | Medium contains a colony stimulating factor |
| | 386 | Medium contains an interleukin |
| | 387 | Medium contains a polypeptide hormone |
| | 388 | Culture medium contains an albumin |
| | 389 | Culture medium contains a transferrin |
| | 390 | Culture medium contains an incompletely defined plant or microbial extract excluding animal extract |
| | 391 | Culture medium contains an animal extract |
| | 393 | Using airlift or laminar flow aeration or foam culture |
| | 394 | Wherein culture vessel is rotated or oscillated or culture is agitated |
| | 395 | Solid support and method of culturing cells on said solid support |
| | 396 | Support is a resin |
| | 397 | Support is a gel surface |
| | 398 | Support is a fiber |
| | 401 | Support is a membrane |
| | 402 | Support is a coated or treated surface |
| | 403 | Support is a suspendable particle |
| | 404 | Culture medium, per se |
| | 410 | PLANT CELL OR CELL LINE, PER SE (E.G., TRANSGENIC, MUTANT, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING, OR PRESERVING PLANT CELL OR CELL LINE; PROCESS OF ISOLATING OR SEPARATING A PLANT CELL OR CELL LINE; PROCESS OF REGENERATING PLANT CELLS INTO TISSUE, PLANT PART, OR PLANT, PER SE, WHERE NO GENOTYPIC CHANGE OCCURS; MEDIUM THEREFORE |
| | 411 | Tomato cell or cell line, per se |
| | 412 | Corn cell or cell line, per se |
| | 414 | Tobacco cell or cell line, per se |
| | 415 | Soybean cell or cell line, per se |
| | 416 | Sunflower cell or cell line, per se |
| | 417 | Potato cell or cell line, per se |
| | 418 | Plant cell or cell line, per se, is pest or herbicide resistant or pest lethal |
| | 419 | Plant cell or cell line, per se, contains exogenous or foreign nucleic acid |
| | 420 | Culture, maintenance, or preservation techniques, per se |
| | 421 | Involving protoplast |
| | 422 | Involving conifer cell or tissue (e.g., pine, spruce, fir, cedar, etc.) |
| | 423 | Involving tomato cell or tissue |
| | 424 | Involving corn cell or tissue |
| | 425 | Involving tobacco cell or tissue |
| | 426 | Involving soybean cell or tissue |
| | 427 | Involving cotton cell or tissue |
| | 428 | Involving sunflower cell or tissue |
| | 429 | Involving potato cell or tissue |
| | 430 | Involving regeneration or propagation into a plant or plant part |
| | 431 | Medium, per se, for culture, maintenance, regeneration, etc. |
| | 242 | SPORE FORMING OR ISOLATING PROCESS |
| | 243 | MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA THEREFOR |
| | 244 | Chemical stimulation of growth or activity by addition of chemical compound which is not an essential growth factor; stimulation of growth by removal of a chemical compound |
| | 245 | Adaptation or attenuation of cells |
| | 246 | Foam culture |
| | 247 | Utilizing media containing lower alkanol (i.e., having one to six carbon atoms) |
| | 248 | Utilizing media containing hydrocarbon |
| | 251 | Utilizing media containing waste sulphite liquor |
| | 252 | Utilizing media containing cellulose or hydrolysates thereof |
| | 252.1 | Bacteria or actinomycetales; media therefor |
| | 252.2 | Rhizobium or agrobacterium |
| | 252.3 | Transformants (e.g., recombinant DNA or vector or foreign or exogenous gene containing, fused bacteria, etc.) |
| | 252.31 | Bacillus (e.g., B. subtilis, B. thuringiensis, etc.) |
| | 252.32 | Brevibacterium or corynebacterium |
| | 252.33 | Escherichia (e.g., E. coli, etc.) |
| | 252.34 | Pseudomonas |
| | 252.35 | Streptomyces |
| | 252.4 | Mixed culture |
| | 252.5 | Bacillus (e.g., B. subtilis, B. thuringiensis, etc.) |
| | 252.6 | Actinoplanes |
| | 252.7 | Clostridium |
| | 252.8 | Escherichia (e.g., E. coli, etc.) or salmonella |
| | 252.9 | Lactobacillus, pediococcus, or leuconostoc |
| | 253.1 | Mycobacterium |
| | 253.2 | Nocardia |
| | 253.3 | Pseudomonas |
| | 253.4 | Streptococcus |
| | 253.5 | Streptomyces |
| | 253.6 | Culture media, per se |
| | 254.1 | Fungi |
